4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
10.23
-0.49 (-4.57%)
Nov 20, 2026, 4:00 PM EST - Market closed
4D Molecular Therapeutics Market Cap
4D Molecular Therapeutics has a market cap or net worth of $576.76 million as of November 20, 2026. It is the 12,749th most valuable company in the world and the 2,533rd biggest in the United States. Its market cap has decreased by 6.53% in one year.
Market Cap
576.76M
Enterprise Value
240.14M
1-Year Change
-6.53%
Global Rank
Country Rank
#2,533 United States
Category
ChartMarket Cap Chart
Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has decreased from $580.38M to $576.76M, a decrease of -0.62%. That is a compound annual growth rate of -0.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 576.76M | 34.60% |
| Dec 31, 2025 | 428.51M | 66.42% |
| Dec 31, 2024 | 257.49M | -70.27% |
| Dec 29, 2023 | 866.19M | 20.40% |
| Dec 30, 2022 | 719.43M | 2.03% |
| Dec 31, 2021 | 705.13M | -35.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 (IPO) | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Annexon | 591.37M |
| Immix Biopharma | 583.33M |
| Design Therapeutics | 577.61M |
| Cullinan Therapeutics | 577.15M |
| Entera Bio | 575.53M |
| DBV Technologies | 571.97M |
| Geron | 560.94M |
| Bicara Therapeutics | 560.31M |